Towards individualized therapy for multiple myeloma :: a guide for choosing treatment that best fits patients /
This very provocative book takes the reader on a "think-out-of-the-box" journey through the development of a treatment regimen for multiple myeloma called "dtZ". It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-c...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Hackensack, NJ :
World Scientific,
©2009.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | This very provocative book takes the reader on a "think-out-of-the-box" journey through the development of a treatment regimen for multiple myeloma called "dtZ". It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically adapted to their individual cancers. These Individualized Anti-Cancer Targeted Therapies (smart bombs) have produced amongst the best responses as well as survival rates for myeloma. Accordingly, the author argues that some patients might even have been "cured" of their cancers. The concepts and logic behind "dtZ" are carefully presented in simple language so that both doctors and patients can easily understand them. Numerous tables and figures are provided, together with clear and simple explanations. This book is a valuable resource for all patients with myeloma who want to get the most out of their treatment by individualizing treatment to suit their needs, particularly for patients who have just been diagnosed with myeloma and who are taking that very important first step in their treatment. It is also a useful guide for doctors, nurses and researchers who treat and/or study myeloma |
| Beschreibung: | 1 online resource (xi, 188 pages) : illustrations |
| Bibliographie: | Includes bibliographical references (pages 179-185) and index. |
| ISBN: | 9789812835802 9812835806 1282442619 9781282442610 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn567713634 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 100323s2009 njua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d N$T |d EBLCP |d IDEBK |d OCLCQ |d CBT |d OCLCQ |d NLGGC |d OCLCO |d OCLCQ |d YDXCP |d OCLCQ |d AGLDB |d TOA |d OCLCO |d JBG |d OCLCO |d ZCU |d OCLCO |d OCLCQ |d MERUC |d OCLCO |d U3W |d OCLCF |d OCLCO |d OCLCQ |d VTS |d ICG |d AU@ |d OCLCO |d OCLCQ |d OCLCO |d REC |d STF |d OCLCO |d DKC |d OCLCO |d OCLCQ |d OCLCO |d M8D |d OCLCO |d UKAHL |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 816360218 | ||
| 020 | |a 9789812835802 |q (electronic bk.) | ||
| 020 | |a 9812835806 |q (electronic bk.) | ||
| 020 | |a 1282442619 | ||
| 020 | |a 9781282442610 | ||
| 035 | |a (OCoLC)567713634 |z (OCoLC)816360218 | ||
| 050 | 4 | |a RC280.B6 |b T46 2009eb | |
| 060 | 4 | |a 2009 G-585 | |
| 060 | 4 | |a WH 540 |b T314t 2009 | |
| 072 | 7 | |a MED |x 062000 |2 bisacsh | |
| 072 | 7 | |a HEA |x 039030 |2 bisacsh | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 082 | 7 | |a 616.99471 |2 22 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Teoh, Gerrard. |0 http://id.loc.gov/authorities/names/n2009183141 | |
| 245 | 1 | 0 | |a Towards individualized therapy for multiple myeloma : |b a guide for choosing treatment that best fits patients / |c Gerrard Teoh. |
| 260 | |a Hackensack, NJ : |b World Scientific, |c ©2009. | ||
| 300 | |a 1 online resource (xi, 188 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references (pages 179-185) and index. | ||
| 505 | 0 | |a Ch. 1. Introduction -- ch. 2. Diagnostic dilemmas -- ch. 3. Shortcomings of Modern-day clinical Trials -- ch. 4. Individualizing core parameters -- ch. 5. Patient compliance -- ch. 6. Multiple myeloma -- ch. 7. Current treatment -- ch. 8. Future opportunities -- ch. 9. Concluding remarks. | |
| 520 | |a This very provocative book takes the reader on a "think-out-of-the-box" journey through the development of a treatment regimen for multiple myeloma called "dtZ". It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically adapted to their individual cancers. These Individualized Anti-Cancer Targeted Therapies (smart bombs) have produced amongst the best responses as well as survival rates for myeloma. Accordingly, the author argues that some patients might even have been "cured" of their cancers. The concepts and logic behind "dtZ" are carefully presented in simple language so that both doctors and patients can easily understand them. Numerous tables and figures are provided, together with clear and simple explanations. This book is a valuable resource for all patients with myeloma who want to get the most out of their treatment by individualizing treatment to suit their needs, particularly for patients who have just been diagnosed with myeloma and who are taking that very important first step in their treatment. It is also a useful guide for doctors, nurses and researchers who treat and/or study myeloma | ||
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Multiple myeloma |x Treatment |v Popular works. | |
| 650 | 0 | |a Multiple myeloma |x Chemotherapy. | |
| 650 | 0 | |a Drug targeting. |0 http://id.loc.gov/authorities/subjects/sh88005350 | |
| 650 | 1 | 2 | |a Multiple Myeloma |x drug therapy |0 https://id.nlm.nih.gov/mesh/D009101Q000188 |
| 650 | 2 | 2 | |a Antineoplastic Agents |x therapeutic use |0 https://id.nlm.nih.gov/mesh/D000970Q000627 |
| 650 | 2 | 2 | |a Drug Delivery Systems |0 https://id.nlm.nih.gov/mesh/D016503 |
| 650 | 4 | |a Oncology. | |
| 650 | 4 | |a Medicine. | |
| 650 | 4 | |a Health & Biological Sciences. | |
| 650 | 6 | |a Myélome multiple |x Traitement |v Ouvrages de vulgarisation. | |
| 650 | 6 | |a Myélome multiple |x Chimiothérapie. | |
| 650 | 6 | |a Médicaments |x Ciblage. | |
| 650 | 7 | |a MEDICAL |x Oncology. |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Cancer. |2 bisacsh | |
| 650 | 7 | |a Drug targeting |2 fast | |
| 655 | 7 | |a Popular works |2 fast | |
| 758 | |i has work: |a Towards individualized therapy for multiple myeloma (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFWBHj6xfk49KwPbTmKcKb |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Teoh, Gerrard. |t Towards individualized therapy for multiple myeloma. |d Singapore ; Hackensack, NJ : World Scientific, ©2009 |z 9789812835796 |w (OCoLC)244765933 |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=305248 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH24686138 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL477255 | ||
| 938 | |a EBSCOhost |b EBSC |n 305248 | ||
| 938 | |a YBP Library Services |b YANK |n 3161684 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn567713634 |
|---|---|
| _version_ | 1816881709116817409 |
| adam_text | |
| any_adam_object | |
| author | Teoh, Gerrard |
| author_GND | http://id.loc.gov/authorities/names/n2009183141 |
| author_facet | Teoh, Gerrard |
| author_role | |
| author_sort | Teoh, Gerrard |
| author_variant | g t gt |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC280 |
| callnumber-raw | RC280.B6 T46 2009eb |
| callnumber-search | RC280.B6 T46 2009eb |
| callnumber-sort | RC 3280 B6 T46 42009EB |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Ch. 1. Introduction -- ch. 2. Diagnostic dilemmas -- ch. 3. Shortcomings of Modern-day clinical Trials -- ch. 4. Individualizing core parameters -- ch. 5. Patient compliance -- ch. 6. Multiple myeloma -- ch. 7. Current treatment -- ch. 8. Future opportunities -- ch. 9. Concluding remarks. |
| ctrlnum | (OCoLC)567713634 |
| dewey-full | 616.99471 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99471 |
| dewey-search | 616.99471 |
| dewey-sort | 3616.99471 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04778cam a2200697 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn567713634</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">100323s2009 njua ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">CBT</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AGLDB</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">JBG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">ICG</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">REC</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">M8D</subfield><subfield code="d">OCLCO</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">816360218</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789812835802</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9812835806</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1282442619</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282442610</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)567713634</subfield><subfield code="z">(OCoLC)816360218</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC280.B6</subfield><subfield code="b">T46 2009eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2009 G-585</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WH 540</subfield><subfield code="b">T314t 2009</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">062000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039030</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MJCL</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.99471</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Teoh, Gerrard.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2009183141</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Towards individualized therapy for multiple myeloma :</subfield><subfield code="b">a guide for choosing treatment that best fits patients /</subfield><subfield code="c">Gerrard Teoh.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Hackensack, NJ :</subfield><subfield code="b">World Scientific,</subfield><subfield code="c">©2009.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xi, 188 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 179-185) and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Ch. 1. Introduction -- ch. 2. Diagnostic dilemmas -- ch. 3. Shortcomings of Modern-day clinical Trials -- ch. 4. Individualizing core parameters -- ch. 5. Patient compliance -- ch. 6. Multiple myeloma -- ch. 7. Current treatment -- ch. 8. Future opportunities -- ch. 9. Concluding remarks.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This very provocative book takes the reader on a "think-out-of-the-box" journey through the development of a treatment regimen for multiple myeloma called "dtZ". It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically adapted to their individual cancers. These Individualized Anti-Cancer Targeted Therapies (smart bombs) have produced amongst the best responses as well as survival rates for myeloma. Accordingly, the author argues that some patients might even have been "cured" of their cancers. The concepts and logic behind "dtZ" are carefully presented in simple language so that both doctors and patients can easily understand them. Numerous tables and figures are provided, together with clear and simple explanations. This book is a valuable resource for all patients with myeloma who want to get the most out of their treatment by individualizing treatment to suit their needs, particularly for patients who have just been diagnosed with myeloma and who are taking that very important first step in their treatment. It is also a useful guide for doctors, nurses and researchers who treat and/or study myeloma</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Multiple myeloma</subfield><subfield code="x">Treatment</subfield><subfield code="v">Popular works.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Multiple myeloma</subfield><subfield code="x">Chemotherapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug targeting.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh88005350</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Multiple Myeloma</subfield><subfield code="x">drug therapy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D009101Q000188</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000970Q000627</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Drug Delivery Systems</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D016503</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health & Biological Sciences.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Myélome multiple</subfield><subfield code="x">Traitement</subfield><subfield code="v">Ouvrages de vulgarisation.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Myélome multiple</subfield><subfield code="x">Chimiothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Ciblage.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Oncology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">Cancer.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug targeting</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Popular works</subfield><subfield code="2">fast</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Towards individualized therapy for multiple myeloma (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFWBHj6xfk49KwPbTmKcKb</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Teoh, Gerrard.</subfield><subfield code="t">Towards individualized therapy for multiple myeloma.</subfield><subfield code="d">Singapore ; Hackensack, NJ : World Scientific, ©2009</subfield><subfield code="z">9789812835796</subfield><subfield code="w">(OCoLC)244765933</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=305248</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH24686138</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL477255</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">305248</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3161684</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Popular works fast |
| genre_facet | Popular works |
| id | ZDB-4-EBA-ocn567713634 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:17:01Z |
| institution | BVB |
| isbn | 9789812835802 9812835806 1282442619 9781282442610 |
| language | English |
| oclc_num | 567713634 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (xi, 188 pages) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | World Scientific, |
| record_format | marc |
| spelling | Teoh, Gerrard. http://id.loc.gov/authorities/names/n2009183141 Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients / Gerrard Teoh. Hackensack, NJ : World Scientific, ©2009. 1 online resource (xi, 188 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references (pages 179-185) and index. Ch. 1. Introduction -- ch. 2. Diagnostic dilemmas -- ch. 3. Shortcomings of Modern-day clinical Trials -- ch. 4. Individualizing core parameters -- ch. 5. Patient compliance -- ch. 6. Multiple myeloma -- ch. 7. Current treatment -- ch. 8. Future opportunities -- ch. 9. Concluding remarks. This very provocative book takes the reader on a "think-out-of-the-box" journey through the development of a treatment regimen for multiple myeloma called "dtZ". It is a firsthand account of how more than 50 patients with myeloma were given a non-toxic, precisely-targeted, anti-cancer treatment that was specifically adapted to their individual cancers. These Individualized Anti-Cancer Targeted Therapies (smart bombs) have produced amongst the best responses as well as survival rates for myeloma. Accordingly, the author argues that some patients might even have been "cured" of their cancers. The concepts and logic behind "dtZ" are carefully presented in simple language so that both doctors and patients can easily understand them. Numerous tables and figures are provided, together with clear and simple explanations. This book is a valuable resource for all patients with myeloma who want to get the most out of their treatment by individualizing treatment to suit their needs, particularly for patients who have just been diagnosed with myeloma and who are taking that very important first step in their treatment. It is also a useful guide for doctors, nurses and researchers who treat and/or study myeloma Print version record. Multiple myeloma Treatment Popular works. Multiple myeloma Chemotherapy. Drug targeting. http://id.loc.gov/authorities/subjects/sh88005350 Multiple Myeloma drug therapy https://id.nlm.nih.gov/mesh/D009101Q000188 Antineoplastic Agents therapeutic use https://id.nlm.nih.gov/mesh/D000970Q000627 Drug Delivery Systems https://id.nlm.nih.gov/mesh/D016503 Oncology. Medicine. Health & Biological Sciences. Myélome multiple Traitement Ouvrages de vulgarisation. Myélome multiple Chimiothérapie. Médicaments Ciblage. MEDICAL Oncology. bisacsh HEALTH & FITNESS Diseases Cancer. bisacsh Drug targeting fast Popular works fast has work: Towards individualized therapy for multiple myeloma (Text) https://id.oclc.org/worldcat/entity/E39PCFWBHj6xfk49KwPbTmKcKb https://id.oclc.org/worldcat/ontology/hasWork Print version: Teoh, Gerrard. Towards individualized therapy for multiple myeloma. Singapore ; Hackensack, NJ : World Scientific, ©2009 9789812835796 (OCoLC)244765933 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=305248 Volltext |
| spellingShingle | Teoh, Gerrard Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients / Ch. 1. Introduction -- ch. 2. Diagnostic dilemmas -- ch. 3. Shortcomings of Modern-day clinical Trials -- ch. 4. Individualizing core parameters -- ch. 5. Patient compliance -- ch. 6. Multiple myeloma -- ch. 7. Current treatment -- ch. 8. Future opportunities -- ch. 9. Concluding remarks. Multiple myeloma Treatment Popular works. Multiple myeloma Chemotherapy. Drug targeting. http://id.loc.gov/authorities/subjects/sh88005350 Multiple Myeloma drug therapy https://id.nlm.nih.gov/mesh/D009101Q000188 Antineoplastic Agents therapeutic use https://id.nlm.nih.gov/mesh/D000970Q000627 Drug Delivery Systems https://id.nlm.nih.gov/mesh/D016503 Oncology. Medicine. Health & Biological Sciences. Myélome multiple Traitement Ouvrages de vulgarisation. Myélome multiple Chimiothérapie. Médicaments Ciblage. MEDICAL Oncology. bisacsh HEALTH & FITNESS Diseases Cancer. bisacsh Drug targeting fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh88005350 https://id.nlm.nih.gov/mesh/D009101Q000188 https://id.nlm.nih.gov/mesh/D000970Q000627 https://id.nlm.nih.gov/mesh/D016503 |
| title | Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients / |
| title_auth | Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients / |
| title_exact_search | Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients / |
| title_full | Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients / Gerrard Teoh. |
| title_fullStr | Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients / Gerrard Teoh. |
| title_full_unstemmed | Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients / Gerrard Teoh. |
| title_short | Towards individualized therapy for multiple myeloma : |
| title_sort | towards individualized therapy for multiple myeloma a guide for choosing treatment that best fits patients |
| title_sub | a guide for choosing treatment that best fits patients / |
| topic | Multiple myeloma Treatment Popular works. Multiple myeloma Chemotherapy. Drug targeting. http://id.loc.gov/authorities/subjects/sh88005350 Multiple Myeloma drug therapy https://id.nlm.nih.gov/mesh/D009101Q000188 Antineoplastic Agents therapeutic use https://id.nlm.nih.gov/mesh/D000970Q000627 Drug Delivery Systems https://id.nlm.nih.gov/mesh/D016503 Oncology. Medicine. Health & Biological Sciences. Myélome multiple Traitement Ouvrages de vulgarisation. Myélome multiple Chimiothérapie. Médicaments Ciblage. MEDICAL Oncology. bisacsh HEALTH & FITNESS Diseases Cancer. bisacsh Drug targeting fast |
| topic_facet | Multiple myeloma Treatment Popular works. Multiple myeloma Chemotherapy. Drug targeting. Multiple Myeloma drug therapy Antineoplastic Agents therapeutic use Drug Delivery Systems Oncology. Medicine. Health & Biological Sciences. Myélome multiple Traitement Ouvrages de vulgarisation. Myélome multiple Chimiothérapie. Médicaments Ciblage. MEDICAL Oncology. HEALTH & FITNESS Diseases Cancer. Drug targeting Popular works |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=305248 |
| work_keys_str_mv | AT teohgerrard towardsindividualizedtherapyformultiplemyelomaaguideforchoosingtreatmentthatbestfitspatients |